Budapest panel asks what holds back AI adoption in pharma: technology, culture or regulation
A Budapest Business Journal rooftop breakfast discussed the impact of AI on the pharmaceutical industry. The question was what slows AI use most: technology, organisational culture, regulation, legacy systems or a lack of skills.
Who is affected and how
- pharmaceuticals
- Hungarian players see organisational and regulatory barriers as obstacles to AI adoption.
Sources
- Rooftop Breakfast Offers Helicopter View of AI’s Impact on Pharma - Budapest Business Journalbbj.hu · Oct 15, 2026
Machine-generated summary based on the titles and excerpts of the source articles. The source article is the authority for the facts. News monitoring, not medical advice: consult a doctor for health decisions.